AGRX - Agile Therapeutics EPS beats by $0.01
Agile Therapeutics (AGRX): Q1 GAAP EPS of -$0.20 beats by $0.01.During the first quarter 2021, total prescriptions were 1,853. The growth was driven by an increase in the number of prescribers, which as of March 31, 2021 was more than 850 HCPs, and growing refill rates. As of March 31, 2021, 447 of prescriptions dispensed at pharmacies were refills. The Company also saw an increase in the number of total prescriptions by prescriber. Press Release
For further details see:
Agile Therapeutics EPS beats by $0.01